Article info
PDFCorrection
Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
Citation
Correction: High response rate with extended dosing of cemiplimab in advanced cutaneous squamous cell carcinoma
Online issue publication
March 27, 2024
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.